| Norman Kenneth Ferguson Iii, OD | |
|
479 Main St, Fryeburg, ME 04037-1118 | |
| (207) 935-3307 | |
| (207) 935-4002 |
| Full Name | Norman Kenneth Ferguson Iii |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 41 Years |
| Location | 479 Main St, Fryeburg, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174592919 | NPI | - | NPPES |
| 09Y002162ME01 | Other | NH | ANTHEM BXBS |
| 010448803001 | Other | CIGNA | |
| 015125 | Other | BXBS | |
| 699TA | Other | CBA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT699TA (Maine) | Primary |
| Provider Name | Dr N Scott Ferguson Optometrist |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1154893386 PECOS PAC ID: 7810326519 Enrollment ID: O20200401000244 |
News Archive
Houston Methodist neurosurgeons and neuroscientists are looking at a new way to classify pituitary tumors that could lead to more precise and accurate diagnosing for patients in the future.
Researchers from the European Molecular Biology Laboratory (EMBL) discovered a new way to make use of drugs' unwanted side effects. They developed a computational method that compares how similar the side effects of different drugs are and predicts how likely the drugs act on the same target molecule. The study, published in Science this week, hints at new uses of marketed drugs.
RTI Biologics Inc., a leading provider of orthopedic and other biologic implants, announced today its intent to acquire privately held Pioneer Surgical Technology, headquartered in Marquette, Mich.
The Northwest's leading deafness charity Deafness Support Network, has welcomed David Cameron's recent announcement of planned reforms to GP surgeries, suggesting it could change the lives of more than ten million people in the UK who are deaf or hard of hearing.
Acknowledging the critical role of Centers for Disease Control and Prevention (CDC) guidelines in ensuring the safety and efficacy of H1N1 vaccinations, Carefx Corporation, a leading provider of interoperable workflow solutions to advance the quality and safety of patient care, today announced that Boston Medical Center (BMC) has deployed the Fusionfx Immunization Management portal designed to enter and track H1N1 vaccination administration history and support broad, community-wide immunization administration tracking.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Norman Kenneth Ferguson Iii, OD 479 Main St, Fryeburg, ME 04037-1118 Ph: (207) 935-3307 | Norman Kenneth Ferguson Iii, OD 479 Main St, Fryeburg, ME 04037-1118 Ph: (207) 935-3307 |
News Archive
Houston Methodist neurosurgeons and neuroscientists are looking at a new way to classify pituitary tumors that could lead to more precise and accurate diagnosing for patients in the future.
Researchers from the European Molecular Biology Laboratory (EMBL) discovered a new way to make use of drugs' unwanted side effects. They developed a computational method that compares how similar the side effects of different drugs are and predicts how likely the drugs act on the same target molecule. The study, published in Science this week, hints at new uses of marketed drugs.
RTI Biologics Inc., a leading provider of orthopedic and other biologic implants, announced today its intent to acquire privately held Pioneer Surgical Technology, headquartered in Marquette, Mich.
The Northwest's leading deafness charity Deafness Support Network, has welcomed David Cameron's recent announcement of planned reforms to GP surgeries, suggesting it could change the lives of more than ten million people in the UK who are deaf or hard of hearing.
Acknowledging the critical role of Centers for Disease Control and Prevention (CDC) guidelines in ensuring the safety and efficacy of H1N1 vaccinations, Carefx Corporation, a leading provider of interoperable workflow solutions to advance the quality and safety of patient care, today announced that Boston Medical Center (BMC) has deployed the Fusionfx Immunization Management portal designed to enter and track H1N1 vaccination administration history and support broad, community-wide immunization administration tracking.
› Verified 2 days ago